CSS_75N95024Q00248_Final.pdf

STREAMLINED SOLICITATION FOR COMMERCIAL ITEMS

COMPETITIVE

COMBINED SYNOPSIS / SOLICITATION

TITLE: Biochemical, Biophysical, and in vivo Testing of Compounds

Introductory Statement

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.

The Government reserves the right to make one award, multiple awards, or no awards as a result of this solicitation.

Solicitation Number and Authority

The solicitation number is 75N95024Q00248 and the solicitation is issued as a Request for Quotation (RFQ).

This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.

Applicable Federal Acquisition Circular

The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2024-03, dated February 23, 2024.

NAICS Code and Small Business Standard

The associated NAICS code is 541380 (Testing Laboratories and Services) and the small business size standard is $19.0 Million.

This requirement is full and open with no set-aside restrictions.

Anticipated Contract Type and Period of Performance

The Government anticipates award of a firm-fixed price purchase order for this acquisition, and the anticipated period of performance is twelve (12) months effective at time of award to begin on 4/29/2024 through 4/28/2025.

Description of Requirement

Statement of Need and Purpose:

The purpose of this requirement is to obtain biochemical, biophysical, and in vivo testing services of 100 compounds in support for a drug discovery campaign to develop a novel therapeutic effective in Alzheimer’s Disease and Related dementias (AD/RD). The scope of this project shall be protein biochemistry, biophysical assays, in vivo microscopy, flow cytometry, proteomics, and cryoEM.

Please refer to Attachment #1 – Statement of Work (SOW) for complete details and specifications.

Applicability of FAR clause 52.212-1

The provision at FAR 52.212-1, Instructions to Offerors – Commercial Products and Commercial Services (SEP 2023) applies to this acquisition. The following instructions are included as an addendum to this provision.

The Quoter shall provide the below information on the first page of its response:

1. Solicitation Number: 75N95024Q00248

2. Quotation Number

3. Submission and Expiration Date of Quotation

4. Company’s Full Name and Address;

5. Company’s UEI Number, CAGE Code, and TIN Number; and

6. Name, Telephone Number, and Email Address of Person Authorized to Provide

Quotation

Responses to this RFQ must include enough information to establish that the Quoter can provide the required services and materials. Specifically, the Quoter shall illustrate that it able to, at a minimum, satisfy the “specific requirements” described within the SOW.

Finally, the Quoter shall provide the following information in its response, as applicable:

a) Part/serial number for each line item;

b) Part description for each line item (in sufficient detail to evaluate compliance with the Purchase Description requirements);

c) Unit and list price for each line item;

d) Country of origin for each line item;

e) The amount of any discounts being provided compared to Quoter’s standard commercial pricing;

f) Delivery terms (including delivery date and Freight on Board (FOB) Point);

g) Warranty terms (including period of warranty and any conditions);

h) Prompt payment discount terms;

i) Any applicable fees, or Federal, State, or local taxes/duties;

j) A statement specifying the extent of agreement with all terms, conditions, and provisions included in the solicitation;

k) Any other information or factors that are relevant to the award decision;

l) Total price (must be clearly indicated and include all line items and any applicable fees or taxes)

For Attachment #3 - 52.204-24 Certification, Quoter is NOT required to complete this certification if it has previously represented that it “does not provide covered telecommunications equipment or services as a part of its offered products or services to the Government in the performance of any contract, subcontract, or other contractual instrument” in paragraph (v) of the provision at FAR 52.212-3, Offeror Representations and Certifications- Commercial Products and Commercial Services (accessible at https://sam.gov).

If the 52.212-3(v) representation was previously completed, Quoter should indicate this is in its response.

For Attachment #4 – FAR 52.212-3 Representations and Certifications, Quoter shall complete only paragraph (b) of this provision if they have completed the annual representations and certification electronically in the System for Award Management (SAM) accessed through https://sam.gov. If the Quoter has NOT completed the annual representations and certifications electronically, they shall complete only paragraphs (c) through (v)) of this provision.

Applicability of FAR provision 52.212-2

The Government will evaluate quotations or offers in accordance with FAR 13.106-2 and award a purchase order from this solicitation to the responsible offeror whose quote conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate quotes:

a. Technical capability of the services offered to meet the Government requirement;

b. Price; and

c. Past performance [see FAR 13.106-2(b)(3)].

Applicability of FAR provision 52.212-3

The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services (Dec 2022), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer.

The provision at FAR 52.212-3, Offeror Representations and Certifications – Commercial Products and Commercial Services (FEB 2024), applies to this acquisition.

This provision is included in full text at Attachment #4 – FAR 52.212-3 Representations and Certifications. Quoter must submit a completed and signed version of this form with its response.

Applicability of FAR clause 52.212-4

The clause at FAR 52.212-4, Contract Terms and Conditions – Commercial Products and Commercial Services (NOV 2023) applies to this acquisition and is incorporated by reference under Attachment #2 – Additional Terms and Conditions.

Applicability of FAR clause 52.212-5

The clause at 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Products and Commercial Services (FEB 2024) applies to this acquisition.

FAR 52.212-5 is included in full text at Attachment #2 – Additional Terms and Conditions.

https://sam.gov/

Additional Requirements

Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount.

All NIH contractors are required to submit invoices through the Department of Treasury’s Invoice Processing Platform (IPP). If the successful quoter is not enrolled in IPP at the time of award, NIH will initiate this process. The vendor will subsequently receive an email with instructions for completing enrollment.

All invoices must be submitted in accordance with Attachment #5 - Invoicing Instructions With IPP to be approved and paid. Each invoice must contain the vendor’s Unique Entity Identifier (UEI), which is located in the System for Award Management (SAM) and replaces the Dun & Bradstreet Data Universal Numbering System (DUNS) number.

Quoters must also possess and maintain an active registration in the System for Award Management (SAM), which can be accessed at www.sam.gov.

Applicability of Defense Priorities and Allocations System (DPAS)

The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.

Question and Response Deadlines

The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All questions must be received by 11:00 A.M., Eastern Standard Time, on April 18, 2024, and reference Solicitation Number 75N95024Q00248. Questions may be submitted electronically to Shivani Patel, Contract Specialist, at shivani.patel@nih.gov.

All quotations must be received by 4:00 P.M., Eastern Standard Time, on April 22, 2024, and reference Solicitation Number 75N95024Q00248. Responses must be submitted electronically to Shivani Patel, Contract Specialist, at shivani.patel@nih.gov.

Fax responses will not be accepted.

Commercial Provisions/Clauses

Please be advised that the NIH is a Federal agency. Your mass-market commercial sales and/or license agreement terms and conditions may include provisions that are customarily found in the commercial sector, but which are not appropriate for a contract with a Federal agency. Specifically, NIH considers any provision in your mass-market commercial sales and/or license agreement terms and conditions to be inappropriate and unenforceable that:

http://www.sam.gov/ mailto:shivani.patel@nih.gov

1) Contravenes a right granted NIH under U.S. copyright law (e.g., fair use, right to archive, copying for interlibrary loan),

2) Violates the Federal Acquisition Regulation or other Federal law (e.g., Antideficiency Act, Principles of Federal Appropriations Law)

3) Departs from reasonable consumer expectations, or

4) Violates fundamental public policy.

The NINDS shall assume that you agree with the statements herein if you submit a quotation and accept the Government’s purchase order.

IMPORTANT

This RFQ does not commit the Government to pay any costs incurred in the preparation of the submission of a quotation or to contract for supplies or services.

Attachment #1 – Purchase Description Attachment #2 – Additional Terms and Conditions Attachment #3 – FAR 52.204-24 Representation Attachment #4 – FAR 52.212-3 Representations and Certifications Attachment #5 - Invoicing Instructions With IPP

RFQ Attachments